相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer
Anubhab Mukherjee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment
Raluca Ioana Teleanu et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Anti-Inflammatory Drugs as Anticancer Agents
Silvia Zappavigna et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Review of Therapeutic Applications of Radiolabeled Functional Nanomaterials
Jongho Jeon
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties
Lawrence D. Mayer et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites
Mohamed F. Attia et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2019)
A Localized Chimeric Hydrogel Therapy Combats Tumor Progression through Alteration of Sphingolipid Metabolism
Sanjay Pal et al.
ACS CENTRAL SCIENCE (2019)
The Role of Tumor Microenvironment in Genomic Instability of Malignant Tumors
F. Gizem Sonugur et al.
FRONTIERS IN GENETICS (2019)
Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities
Fatemeh Farjadian et al.
NANOMEDICINE (2019)
Polymer-drug conjugate therapeutics: advances, insights and prospects
Iriny Ekladious et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications
Dalong Ni et al.
ACCOUNTS OF CHEMICAL RESEARCH (2018)
Nanogel-Incorporated Injectable Hydrogel for Synergistic Therapy Based on Sequential Local Delivery of Combretastatin-A4 Phosphate (CA4P) and Doxorubicin (DOX)
Wen Jing Yang et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
Jeffrey E. Lancet et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Polypeptide-Based Conjugates as Therapeutics: Opportunities and Challenges
Oleksandr Zagorodko et al.
MACROMOLECULAR BIOSCIENCE (2017)
Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma
Robert J. Motzer et al.
ONCOLOGIST (2017)
Polymer therapeutics at a crossroads? Finding the path for improved translation in the twenty-first century
Ruth Duncan
JOURNAL OF DRUG TARGETING (2017)
Curcumin/sunitinib co-loaded BSA-stabilized SPIOs for synergistic combination therapy for breast cancer
Sunhui Chen et al.
JOURNAL OF MATERIALS CHEMISTRY B (2017)
A multicenter, phase II study of CPX-1 liposome injection in patients (pts) with advanced colorectal cancer (CRC)
G. Batist et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities
Jinming Zhang et al.
ACTA BIOMATERIALIA (2017)
Enhanced anticancer effect of Combretastatin A-4 phosphate when combined with vincristine in the treatment of hepatocellular carcinoma
Esam M. Aboubakr et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Nanoformulation-based sequential combination cancer therapy
Gayong Shim et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Nanoformulations for combination or cascade anticancer therapy
Lei Miao et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Precise Engineering of Prodrug Cocktails into Single Polymeric Nanoparticles for Combination Cancer Therapy: Extended and Sequentially Controllable Drug Release
Hangxiang Wang et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor
Xiaoyu Li et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Recent advances of cocktail chemotherapy by combination drug delivery systems
Quanyin Hu et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Combinatorial Polymeric Conjugated Micelles with Dual Cytotoxic and Antiangiogenic Effects for the Treatment of Ovarian Cancer
Deepa A. Rao et al.
CHEMISTRY OF MATERIALS (2016)
Indium-based and iodine-based labeling of HPMA copolymer-epirubicin conjugates: Impact of structure on the in vivo fate
Libin Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives
Rui Xue Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Emerging Frontiers in Drug Delivery
Mark W. Tibbitt et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Multifunctional Polymeric Nanosystems for Dual-Targeted Combinatorial Chemo/Angiogenesis Therapy of Tumors
Fatima Zohra Dahmani et al.
ADVANCED HEALTHCARE MATERIALS (2016)
Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
Hiroshi Maeda
ADVANCED DRUG DELIVERY REVIEWS (2015)
Clinical Translation of Nanomedicine
Yuanzeng Min et al.
CHEMICAL REVIEWS (2015)
Multifunctional hollow gold nanoparticles designed for triple combination therapy and CT imaging
Jaesook Park et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Codelivery of Sorafenib and Curcumin by Directed Self-Assembled Nanoparticles Enhances Therapeutic Effect on Hepatocellular Carcinoma
Haiqiang Cao et al.
MOLECULAR PHARMACEUTICS (2015)
Programmable nanomedicine: synergistic and sequential drug delivery systems
Dennis B. Pacardo et al.
NANOSCALE (2015)
Cancer nanomedicine: from targeted delivery to combination therapy
Xiaoyang Xu et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Lipid-Based Drug Carriers for Prodrugs to Enhance Drug Delivery
Jennica L. Zaro
AAPS JOURNAL (2015)
Chemotherapy in the Setting of Severe Liver Dysfunction in Patients with Metastatic Colorectal Cancer
Pashtoon Murtaza Kasi et al.
CASE REPORTS IN ONCOLOGICAL MEDICINE (2015)
Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial
B. Escudier et al.
BRITISH JOURNAL OF CANCER (2014)
Development of Novel ADCs: Conjugation of Tubulysin Analogues to Trastuzumab Monitored by Dual Radiolabeling
Ruth Cohen et al.
CANCER RESEARCH (2014)
Tumor and the Microenvironment: A Chance to Reframe the Paradigm of Carcinogenesis?
Mariano Bizzarri et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Polymer therapeutics-prospects for 21st century: The end of the beginning
Ruth Duncan et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Validation of tumour models for use in anticancer nanomedicine evaluation: the EPR effect and cathepsin B-mediated drug release rate
Ruth Duncan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
A Pharmacokinetic Overview of Nanotechnology-Based Drug Delivery Systems: An ADME-Oriented Approach
Mehrdad Hamidi et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2013)
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Oktay Tacar et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicines
Falk Ehmann et al.
NANOMEDICINE (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
177Lu-labeled HPMA copolymers utilizing cathepsin B and S cleavable linkers: Synthesis, characterization and preliminary in vivo investigation in a pancreatic cancer model
Sunny M. Ogbomo et al.
NUCLEAR MEDICINE AND BIOLOGY (2013)
Managing Toxicities Associated With Antiangiogenic Biologic Agents in Combination With Chemotherapy for Metastatic Colorectal Cancer
Nina N. Grenon
CLINICAL JOURNAL OF ONCOLOGY NURSING (2013)
Administration, distribution, metabolism and elimination of polymer therapeutics
Ela Markovsky et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Cancer prevention by targeting angiogenesis
Adriana Albini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Spatiotemporally Controlled Co-delivery of Anti-vasculature Agent and Cytotoxic Drug by Octreotide-Modified Stealth Liposomes
Wenbing Dai et al.
PHARMACEUTICAL RESEARCH (2012)
Balancing repair and tolerance of DNA damage caused by alkylating agents
Dragony Fu et al.
NATURE REVIEWS CANCER (2012)
The Evolving War on Cancer
Daniel A. Haber et al.
CELL (2011)
Polymer therapeutics as nanomedicines: new perspectives
Ruth Duncan
CURRENT OPINION IN BIOTECHNOLOGY (2011)
First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
Eric J. Feldman et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Materializing sequential killing of tumor vasculature and tumor cells via targeted polymeric micelle system
Yiguang Wang et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Antiangiogenic Antitumor Activity of HPMA Copolymer-Paclitaxel-Alendronate Conjugate on Breast Cancer Bone Metastasis Mouse Model
Keren Miller et al.
MOLECULAR PHARMACEUTICS (2011)
Nanomedicine(s) under the Microscope
Ruth Duncan et al.
MOLECULAR PHARMACEUTICS (2011)
Polymeric Nanoparticles with Precise Ratiometric Control over Drug Loading for Combination Therapy
Santosh Aryal et al.
MOLECULAR PHARMACEUTICS (2011)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
Sunitinib Acts Primarily on Tumor Endothelium rather than Tumor Cells to Inhibit the Growth of Renal Cell Carcinoma
Dan Huang et al.
CANCER RESEARCH (2010)
Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: In vitro and in vivo studies
Yi-fei Zhang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Impact of Nanotechnology on Drug Delivery
Omid C. Farokhzad et al.
ACS NANO (2009)
Combination therapy: Opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines
Francesca Greco et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
The Control of Vascular Integrity by Endothelial Cell Junctions: Molecular Basis and Pathological Implications
Elisabetta Dejana et al.
DEVELOPMENTAL CELL (2009)
Mechanisms of drug combinations: interaction and network perspectives
Jia Jia et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy
Mayumi Ono
CANCER SCIENCE (2008)
Multi-functional nanocarriers to overcome tumor drug resistance
Lara S. Jabr-Milane et al.
CANCER TREATMENT REVIEWS (2008)
Randomized phase III trial comparing single-agent paclitaxel poliglumex (CT-2103, PPX) with single-agent gemcitabine or vinorelbine for the treatment of PS 2 patients with chemotherapy-naive advanced non-small cell lung cancer
Mary E. R. O'Brien et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naive advanced non-small cell lung cancer
Corey J. Langer et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Somatostatin, cortistatin and their receptors in tumours
M. Volante et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
Optimizing combination chemotherapy by controlling drug ratios
Lawrence D. Mayer et al.
MOLECULAR INTERVENTIONS (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Polymer conjugates as anticancer nanomedicines
Ruth Duncan
NATURE REVIEWS CANCER (2006)
Antimalarial drug synergism and antagonism: Mechanistic and clinical significance
A Bell
FEMS MICROBIOLOGY LETTERS (2005)
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
S Sengupta et al.
NATURE (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Timeline - Chemotherapy and the war on cancer
BA Chabner et al.
NATURE REVIEWS CANCER (2005)
Prospective strategies to enforce selectively cell death in cancer cells
MV Blagosklonny
ONCOGENE (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Fundamental concepts of the angiogenic process
J Folkman
CURRENT MOLECULAR MEDICINE (2003)
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
JC Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
DNA and its associated processes as targets for cancer therapy
LH Hurley
NATURE REVIEWS CANCER (2002)
分享论文
